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The STING signaling pathway has emerged as a central
TLR-independent mediator of host innate defense in
response to sensing cytosolic nucleic acids, either
through direct binding of CDNs secreted by intracellular
bacteria, or through binding of a structurally distinct
CDN produced by a host cell receptor, cyclic GMP-
AMP (cGAMP) synthase (cGAS), in response to binding
cytosolic double-stranded DNA. Binding of CDNs to
STING initiates a signaling cascade through the TBK-1/
IRF-3 axis to induce type I interferon (IFN) and other
co-regulated genes. Discovered recently, CDNs synthe-
sized by cGAS and bacteria are structurally distinct. The
cGAS product, termed non-canonical CDN, has a phos-
phate bridge with both 2’-5’ and 3’-5’ linkages that
reportedly increases its affinity for STING by 200-fold.
Here we show in a panel of human donors that the non-
canonical linkage confers significantly increased activity
of CDNs to activate PBMCs, as measured by expression
of IFN and NF-B dependent cytokines, as compared to
CDNs with canonical 3’-5’ phosphate linkages. By con-
ducting Immunogenicity-Structure Activity Relationship
studies in vitro and in various animal models of infection
and cancer, we selected synthetic derivatives of native
CDNs produced by bacteria or eukaryotic cells with
increased potency. CDN derivatives with sulfur atoms at
non-bridging oxygens of the internucleotide phosphate
bridge were resistant to digestion with phosphodiester-
ase. Surprisingly, R,R di-thio CDN diastereomers induced
higher levels of IFN in vitro, and induced a higher magni-
tude of peak and memory antigen-specific CD4 and CD8
T cell responses correlated with protective immunity, as
compared to either the R,S di-thio CDN diastereomer, or
di-oxo CDN. CDNs based on adenosine nucleotides were
comparatively independent of host cell permeabilization
to activate STING signaling. We applied this finding to
enhance the activity of immunotherapy regimens utiliz-
ing irradiated GM-CSF expressing tumor cell vaccines.
Co-formulation with R,R dithio-c-di-AMP significantly
inhibited tumor growth in several models, correlated
with increased mobilization and activation of dendritic
cells, increased tumor lymphocyte infiltration, and T cell
immunity. Immunologic potency of CDNs was essentially
lost in mice encoding a non-functional STING allele.
Collectively, CDNs have high translation potential for
diverse applications in clinical oncology.
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